{
    "clinical_study": {
        "@rank": "112503", 
        "acronym": "PANDA", 
        "arm_group": [
            {
                "arm_group_label": "Degarelix", 
                "arm_group_type": "Experimental", 
                "description": "Degarelix 240/80 mg"
            }, 
            {
                "arm_group_label": "Goserelin", 
                "arm_group_type": "Active Comparator", 
                "description": "Goserelin 3.6 mg"
            }
        ], 
        "brief_summary": {
            "textblock": "One month degarelix/comparator treatment for prostate cancer in Chinese population"
        }, 
        "brief_title": "One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Population", 
        "completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Prostate Cancer", 
        "condition_browse": {
            "mesh_term": "Prostatic Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Chinese male over 18 years\n\n          -  Adenocarcinoma of the prostate\n\n          -  Relevant disease status based on lab values and as judged by the physician\n\n          -  Life expectancy of at least a year\n\n        Exclusion Criteria:\n\n          -  No previous hormonal treatment for prostate cancer\n\n          -  Considered to be candidate for curative therapy\n\n          -  No risk or history of any serious or significant health condition\n\n          -  Has received an investigational drug within the last 28 days and no  previous\n             treatment with degarelix"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "280", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 5, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01744366", 
            "org_study_id": "000006"
        }, 
        "intervention": [
            {
                "arm_group_label": "Degarelix", 
                "intervention_name": "Degarelix", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Goserelin", 
                "intervention_name": "Goserelin", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Goserelin"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 26, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "state": "Beijing"
                    }, 
                    "name": "Cancer Institute & Hospital. Chinese Academy of Medical Sciences"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chongqing", 
                        "country": "China", 
                        "state": "Chongqing"
                    }, 
                    "name": "Affiliated Southwest Hospital of 3rd Military Medical University of People's Liberation Army"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Guangzhou", 
                        "country": "China", 
                        "state": "Guangdong"
                    }, 
                    "name": "1st Afilliated Hospital of Guangzhou Medical College"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wuhan", 
                        "country": "China", 
                        "state": "Hubei"
                    }, 
                    "name": "Renmin Hospital of Wuhan University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Xi'an", 
                        "country": "China", 
                        "state": "Shanxi"
                    }, 
                    "name": "2nd.Affiliated Hospital of Xi'an Jiaotong University College of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hangzhou", 
                        "country": "China", 
                        "state": "Zhejiang"
                    }, 
                    "name": "1st Hospital Affiliated to Zhejiang University Medical School"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China"
                    }, 
                    "name": "Peking University 3rd Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China"
                    }, 
                    "name": "Peking Union Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China"
                    }, 
                    "name": "Beijing Hospital of Ministry of Health"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China"
                    }, 
                    "name": "Peking University People's Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Changchun", 
                        "country": "China"
                    }, 
                    "name": "1st Hospital of Jilin University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Changsha", 
                        "country": "China"
                    }, 
                    "name": "Hunan Cancer Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Changsha", 
                        "country": "China"
                    }, 
                    "name": "Hunan Province People's Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chengdu", 
                        "country": "China"
                    }, 
                    "name": "People's Hospital of Sichuan"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hangzhou", 
                        "country": "China"
                    }, 
                    "name": "2nd Hospital Affiliated to Zhejiang University Medical School"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lanzhou", 
                        "country": "China"
                    }, 
                    "name": "1st Hospital of Lanzhou University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nanchang", 
                        "country": "China"
                    }, 
                    "name": "1st Affiliated Hospital of Nanchang University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nanjing", 
                        "country": "China"
                    }, 
                    "name": "Drum Tower Hospital Affiliated to Nanjing University Medical School"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nanjing", 
                        "country": "China"
                    }, 
                    "name": "1st Affiliated Hospital of Nanjing Medical University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China"
                    }, 
                    "name": "Shanghai 5th People's Hospital affilicated to Fudan University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China"
                    }, 
                    "name": "Fudan University Shanghai Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China"
                    }, 
                    "name": "Shanghai Changhai Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China"
                    }, 
                    "name": "Huashan Hospital of Fudan University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shenyang", 
                        "country": "China"
                    }, 
                    "name": "1st Hospital Affiliated to China Medical University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Suzhou", 
                        "country": "China"
                    }, 
                    "name": "2nd Hospital Affiliated to Suzhou University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tianjin", 
                        "country": "China"
                    }, 
                    "name": "2nd Hospital of Tianjin Medical University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wuhan", 
                        "country": "China"
                    }, 
                    "name": "Zhongnan Hospital of Wuhan University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wuhan", 
                        "country": "China"
                    }, 
                    "name": "Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wuxi", 
                        "country": "China"
                    }, 
                    "name": "1st People's Hospital of Wuxi"
                }
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "An Open-label, Multi-centre, Randomised, Parallel-group Trial, Comparing Efficacy and Safety of Degarelix One-month Dosing Regimen With Goserelin in Chinese Patients With Prostate Cancer Requiring Androgen Ablation Therapy", 
        "overall_official": {
            "affiliation": "Ferring Pharmaceuticals", 
            "last_name": "Clinical Development Support", 
            "role": "Study Director"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Cumulative probability of testosterone at castrate level (\u22640.5 ng/mL)", 
            "safety_issue": "No", 
            "time_frame": "Day 28 to Day 364"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01744366"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Proportion of patients with testosterone levels \u22640.5 ng/mL", 
                "safety_issue": "No", 
                "time_frame": "at Day 3"
            }, 
            {
                "measure": "Percentage change in prostate-specific antigen (PSA)", 
                "safety_issue": "No", 
                "time_frame": "from baseline to Day 28"
            }, 
            {
                "measure": "Changes in testosterone and PSA levels", 
                "safety_issue": "No", 
                "time_frame": "Day 0 to 364"
            }, 
            {
                "measure": "Significant changes in laboratory values", 
                "safety_issue": "Yes", 
                "time_frame": "Day 0 to Day 364"
            }, 
            {
                "measure": "Significant changes in vital signs", 
                "safety_issue": "Yes", 
                "time_frame": "Day 0 to Day 364"
            }, 
            {
                "measure": "Significant changes in body weight", 
                "safety_issue": "Yes", 
                "time_frame": "Day 0 to Day 364"
            }, 
            {
                "measure": "Frequency and severity of adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "Day 0 to Day 364"
            }, 
            {
                "description": "PSA failure defined as two consecutive (at least two weeks apart) increase of 50 percentage and at least 5ng/mL increase compared to nadir", 
                "measure": "Cumulative probability of no PSA failure", 
                "safety_issue": "No", 
                "time_frame": "Day 0 to Day 364"
            }
        ], 
        "source": "Ferring Pharmaceuticals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ferring Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}